Status:
UNKNOWN
Can Cytokines Predict the Severity of Acute Mucositis and the Need for Gastrostomy Tubes (PEG)?
Lead Sponsor:
Hadassah Medical Organization
Conditions:
Oral Mucositis
Xerostomia
Eligibility:
All Genders
18-85 years
Brief Summary
Mucositis and xerostomia are the most common complications of head and neck (H\&N) irradiation, and the combination of chemotherapy and radiation therapy is associated with a significantly higher rate...
Detailed Description
Mucositis has a significant detrimental effect on patient's quality of life in terms of pain, ability to eat, to swallow and talk. It may be so severe that an interruption of therapy is required, cons...
Eligibility Criteria
Inclusion
- Patients with H\&N epithelial cancer (nasopharynx, oropharynx, oral cavity - tongue, buccal mucosae and palate, larynx and hypopharynx)
- Treated with definitive chemo-radiation treatment and follow up
- Male and female patients will be included, with an age ranging between 18- 85 years
Exclusion
- Soldiers, prisoners and pregnant women will be excluded.
Key Trial Info
Start Date :
Trial Type :
OBSERVATIONAL
Allocation :
ESTIMATED
End Date :
May 1 2011
Estimated Enrollment :
35 Patients enrolled
Trial Details
Trial ID
NCT00431925
End Date
May 1 2011
Last Update
August 10 2007
Active Locations (1)
Enter a location and click search to find clinical trials sorted by distance.
1
Hadassah Medical Organization
Jerusalem, Israel, 91120